Company intelligence / Profile preview

Cellex Cell Professionals

Dresden, Saxony, Germanycellex.me ↗

Ownership: Private
Employees: ~260
Development stage: Other

Overview

Cellex is a leading European CDMO with over 10 years' experience, manufacturing autologous and allogeneic cell and gene therapy products, including commercial CAR-T products. It is involved in producing 3 of the 6 approved CAR-T therapies in the EU and has manufactured over 5,800 CGT/ATMP batches, supporting both clinical development and commercial supply for major pharma and biotech partners.

Therapeutic areas: Oncology
Modalities: Cell therapyGene therapyCAR-T cell therapyAutologous cell therapyAllogeneic cell therapy
Industry: Contract Manufacturing Organization

Partnerships

Several major global pharmaceutical and biotech companies (names not specifically disclosed publicly)CGT Global

Beyond the preview

Go deeper on Cellex Cell Professionals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellex Cell Professionals.